Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Index funds combine broad market exposure with low expenses, often improving risk-adjusted returns for long-term investors. This guide explains the appeal.
22,458 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Bitcoin’s calm price action has persisted through February 2026, but traders warn the lull may be masking fading ETF ...
Bitcoin fell below $63,000 as a broad crypto rout intensified. Analysts say $150 billion gone from the market’s total...
Crypto prediction markets are growing as traders bet on real-world outcomes. The space blends crypto tech with real e...
FedEx says it will return tariff refunds to customers who paid them after a Supreme Court ruling curbed IEEPA tariffs...
A U.S. strike on Iran triggered a rapid reevaluation of crypto mining and Bitcoin hashrate resilience, with analysts ...
Venture capital veteran Alfred Lin of Sequoia counters doom-laden SaaS forecasts, arguing AI-driven productivity and ...
A veteran's take on holding (onon) 2025 earnings: what to watch, where margins could move, and how to plan for the Q4...
Claude AI projects a multi-year rally for XRP, SOL, and ADA, with end-2026 targets that would mark fresh highs amid i...
Solv Protocol confirms a crypto exploit drained about $2.7 million from a Bitcoin yield vault, impacting roughly 10 u...
XRP is positioned for a potential re-test of $3 in 2026 if a confluence of five catalysts aligns. Analysts point to B...
Global markets tumble as crude crosses the $100 mark, triggering a broad risk-off move and rising household costs. He...